David Oupicky

Affiliations: 
Biomedical Engineering Wayne State University, Detroit, MI, United States 
Area:
Biomedical Engineering
Google:
"David Oupicky"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wu P, Luo X, Wu H, et al. (2020) Combined Hydrophobization of Polyethylenimine with Cholesterol and Perfluorobutyrate Improves siRNA Delivery. Bioconjugate Chemistry
Li Z, Chen G, Ding L, et al. (2019) Increased Survival by Pulmonary Treatment of Established Lung Metastases with Dual STAT3/CXCR4 Inhibition by siRNA Nanoemulsions. Molecular Therapy : the Journal of the American Society of Gene Therapy
Zou Y, Wan L, Blacklock J, et al. (2019) In Situ AFM Analysis Investigating Disassembly of DNA Nanoparticles and Nanofilms. Methods in Molecular Biology (Clifton, N.J.). 1943: 199-209
Zhou Z, Zhang Q, Zhang M, et al. (2018) ATP-activated decrosslinking and charge-reversal vectors for siRNA delivery and cancer therapy. Theranostics. 8: 4604-4619
Wu P, Luo X, Wu H, et al. (2018) Cholesterol Modification Enhances Antimetastatic Activity and siRNA Delivery Efficacy of Poly(ethylenimine)-Based CXCR4 Antagonists. Macromolecular Bioscience. e1800234
Zhou Z, Li C, Zhang M, et al. (2018) Charge and Assembly Reversible Micelles Fuelled by Intracellular ATP for Improved siRNA Transfection. Acs Applied Materials & Interfaces
Zhou Z, Zhang M, Liu Y, et al. (2018) Reversible Covalent-Crosslinked Polycations with Enhanced Stability and ATP-Responsive Behavior for Improved siRNA Delivery. Biomacromolecules
Yang X, Li H, Qian C, et al. (2018) Near-infrared light-activated IR780-loaded liposomes for anti-tumor angiogenesis and Photothermal therapy. Nanomedicine : Nanotechnology, Biology, and Medicine
Li H, Yang X, Gao F, et al. (2018) Bioreduction-ruptured nanogel for switch on/off release of Bcl2 siRNA in breast tumor therapy. Journal of Controlled Release : Official Journal of the Controlled Release Society
Kularatne RN, Washington KE, Bulumulla C, et al. (2018) Histone Deacetylase Inhibitor (HDACi) Conjugated Polycaprolactone for Combination Cancer Therapy. Biomacromolecules
See more...